Literature DB >> 27350731

MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.

Wei-Zhong Sheng1, Yu-Sheng Chen1, Chuan-Tao Tu1, Juan He1, Bo Zhang1, Wei-Dong Gao1.   

Abstract

AIM: To explore the regulatory mechanism of the target gene of microRNA-21 (miR-21), phosphatase gene (PTEN), and its downstream proteins, protein kinase B (AKT) and phosphatidylinositol 3-kinase (PI3K), in colorectal cancer (CRC) cells.
METHODS: Quantitative real-time PCR (qRT-PCR) and Western blot were used to detect the expression levels of miR-21 and PTEN in HCT116, HT29, Colo32 and SW480 CRC cell lines. Also, the expression levels of PTEN mRNA and its downstream proteins AKT and PI3K in HCT116 cells after downregulating miR-21 were investigated.
RESULTS: Comparing the miR-21 expression in CRC cells, the expression levels of miR-21 were highest in HCT116 cells, and the expression levels of miR-21 were lowest in SW480 cells. In comparing miR-21 and PTEN expression in CRC cells, we found that the protein expression levels of miR-21 and PTEN were inversely correlated (P < 0.05); when miR-21 expression was reduced, mRNA expression levels of PTEN did not significantly change (P > 0.05), but the expression levels of its protein significantly increased (P < 0.05). In comparing the levels of PTEN protein and downstream AKT and PI3K in HCT116 cells after downregulation of miR-21 expression, the levels of AKT and PI3K protein expression significantly decreased (P < 0.05).
CONCLUSION: PTEN is one of the direct target genes of miR-21. Thus, phosphatase gene and its downstream AKT and PI3K expression levels can be regulated by regulating the expression levels of miR-21, which in turn regulates the development of CRC.

Entities:  

Keywords:  Colorectal cancer; MicroRNA-21; Phosphatase and tensin homolog; Phosphatidylinositol 3-kinase; Protein kinase B

Mesh:

Substances:

Year:  2016        PMID: 27350731      PMCID: PMC4917613          DOI: 10.3748/wjg.v22.i24.5532

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  50 in total

Review 1.  Kinases, tails and more: regulation of PTEN function by phosphorylation.

Authors:  Rita Fragoso; João T Barata
Journal:  Methods       Date:  2014-10-22       Impact factor: 3.608

Review 2.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

Review 3.  Brain overgrowth in disorders of RTK-PI3K-AKT signaling: a mosaic of malformations.

Authors:  Robert F Hevner
Journal:  Semin Perinatol       Date:  2014-11-26       Impact factor: 3.300

4.  PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.

Authors:  Jinye Xu; Junbo Cai; Xiaoyan Jin; Jingjin Yang; Qinyan Shen; Xiaofei Ding; Yong Liang
Journal:  Oncol Rep       Date:  2015-06-30       Impact factor: 3.906

5.  HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis.

Authors:  Guohua Wang; Yejie Shi; Xiaoyan Jiang; Rehana K Leak; Xiaoming Hu; Yun Wu; Hongjian Pu; Wei-Wei Li; Bo Tang; Yun Wang; Yanqin Gao; Ping Zheng; Michael V L Bennett; Jun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

6.  Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.

Authors:  Monika Paul-Samojedny; Adam Pudełko; Renata Suchanek-Raif; Małgorzata Kowalczyk; Anna Fila-Daniłow; Paulina Borkowska; Jan Kowalski
Journal:  Tumour Biol       Date:  2014-12-14

7.  PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.

Authors:  Sabine Mueller; Joanna Phillips; Arzu Onar-Thomas; Eloy Romero; Shichun Zheng; John K Wiencke; Sean M McBride; Cynthia Cowdrey; Michael D Prados; William A Weiss; Mitchel S Berger; Nalin Gupta; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2012-06-29       Impact factor: 12.300

8.  MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.

Authors:  Longlong Bao; Yan Yan; Can Xu; Weidan Ji; Shuwen Shen; Gaoya Xu; Yong Zeng; Bin Sun; Haihua Qian; Lei Chen; Mengchao Wu; Changqing Su; Jie Chen
Journal:  Cancer Lett       Date:  2013-05-14       Impact factor: 8.679

Review 9.  MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer.

Authors:  Marion Gayral; Sébastien Jo; Naima Hanoun; Alix Vignolle-Vidoni; Hubert Lulka; Yannick Delpu; Aline Meulle; Marlène Dufresne; Marine Humeau; Maël Chalret du Rieu; Barbara Bournet; Janick Sèlves; Rosine Guimbaud; Nicolas Carrère; Louis Buscail; Jérôme Torrisani; Pierre Cordelier
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.

Authors:  Shou-Mei Yang; Cheng Huang; Xiao-Feng Li; Ming-Zhe Yu; Yong He; Jun Li
Journal:  Toxicology       Date:  2013-03-04       Impact factor: 4.221

View more
  6 in total

1.  XRCC1 Gene Polymorphisms and miR-21 Expression in Patients with Colorectal Carcinoma.

Authors:  Hanan Fouad; Dina Sabry; Heba Morsi; Hany Shehab; Naglaa F Abuzaid
Journal:  Eurasian J Med       Date:  2017-06

2.  Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.

Authors:  Wanbo Liu; Sheng Chen; Bing Liu
Journal:  Pediatr Surg Int       Date:  2016-09-06       Impact factor: 1.827

3.  Anti-apoptotic Effect of MiR-223-3p Suppressing PIK3C2A in Cardiomyocytes from Myocardial Infarction Rat Through Regulating PI3K/Akt Signaling Pathway.

Authors:  Liu Xiaoyu; Zhang Wei; Zhao Ming; Jia Guowei
Journal:  Cardiovasc Toxicol       Date:  2021-05-17       Impact factor: 3.231

Review 4.  MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.

Authors:  Ashlee M Strubberg; Blair B Madison
Journal:  Dis Model Mech       Date:  2017-03-01       Impact factor: 5.758

Review 5.  MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers.

Authors:  Chen Li; Kai Zhang; Jing Chen; Longbang Chen; Rui Wang; Xiaoyuan Chu
Journal:  Oncotarget       Date:  2017-02-14

Review 6.  Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy.

Authors:  Shanshan Wei; Wenwei Hu; Jun Feng; Yiting Geng
Journal:  Cell Commun Signal       Date:  2022-09-21       Impact factor: 7.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.